RANI THERAPEUTICS HOLDINGS INC. - CLASS A COMMON
2.0800
25-نوفمبر-24 11:42:57
15 متأخرة بدقائق
الأسهم
0.0000
0.00%
نطاق اليوم
2.0600 - 2.1600
ISIN
N/A
المصدر
NASDAQ
-
Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study
06 ديسمبر 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10 نوفمبر 2022 15:05:01 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the Stifel Healthcare Conference
09 نوفمبر 2022 15:05:02 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update
24 أكتوبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06 سبتمبر 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock
11 أغسطس 2022 22:47:30 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock
10 أغسطس 2022 16:28:34 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update
10 أغسطس 2022 15:28:17 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis
10 أغسطس 2022 15:23:29 بحسب Nasdaq GlobeNewswire
-
08 أغسطس 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update
11 مايو 2022 15:05:01 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at Upcoming Investor Conferences
03 مايو 2022 15:05:01 بحسب Nasdaq GlobeNewswire
-
03 مايو 2022 06:00:02 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
07 أبريل 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
29 مارس 2022 15:05:00 بحسب Nasdaq GlobeNewswire
-
23 مارس 2022 19:38:02 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis
23 مارس 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
23 فبراير 2022 07:00:02 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Appoints Lisa Rometty to Board of Directors
07 يناير 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update
15 نوفمبر 2021 18:31:25 بحسب Nasdaq GlobeNewswire